EpiBiologics Competitors and Similar CompaniesClear all

EpiBiologics's competitors and similar companies include Aurion Biotech, Pluri Biotech, Bolt Biotherapeutics and Eleven Tx.
EpiBiologics
EpiBiologics
EpiBiologics is a company that provides a protein degradation platform.
Aurion Biotech
Aurion Biotech
Aurion Biotech is a clinical stage biotech company that develops a platform of therapies to cure blindness.
Pluri Biotech
Pluri Biotech
Pluri Biotech (פלורי ביוטק בע"מ, formerly Pluristem Therapeutics) is a clinical-stage biotherapy company developing cell therapies.
Bolt Biotherapeutics
Bolt Biotherapeutics
Bolt Biotherapeutics is a biotechnology company developing immunotherapeutics for multiple types of cancer.
Eleven Tx
Eleven Tx
Eleven Therapeutics is a biotechnology company focused on using ribonucleic acid interference (RNAi) for nucleic acid therapeutics.
Founding Date
Founding Date
2022
Founding Date
2021
Founding Date
2003
Founding Date
2015
Founding Date
2020
Type
Type
Private
Type
Private
Type
Public
Type
Public
Type
Private
Tags
Locations
Locations
San Mateo, US HQ
Locations
Seattle, US HQ
Locations
Haifa, IL HQ
Potsdam, DE
Locations
Redwood City, US HQ
Locations
Tel Aviv-Yafo, IL HQ
Cambridge, GB
Boston, US
Employees
Employees
40
Employees
901% decrease
Employees
106
Employees
5248% decrease
Employees
29
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
25.2 m
Valuation ($)
25.6 m
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$1.3m (FY, 2025)
Revenue (est.)
$7.7m (FY, 2025)
Revenue (est.)
N/A
Net income
Net income
N/A
Net income
N/A
Net income
($23.3m) (FY, 2025)
Net income
($33.4m) (FY, 2025)
Net income
N/A

Funding

Latest funding round
Latest funding round
$ 50m (about 3 years ago)
Latest funding round
$ 120m (about 4 years ago)
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 22m (almost 4 years ago)
Total funding raised
Total funding raised
$ 50m
Total funding raised
$ 120m
Total funding raised
$ 78.4m
Total funding raised
$ 177.5m
Total funding raised
$ 22m
For sources of this data, please see the company profile

View Company Profiles

Aurion Biotech
HQ
Seattle, US
Employees
90↓ 1% decrease

Aurion Biotech is a clinical stage biotech company that develops a platform of therapies to cure blindness.

View company
Pluri Biotech
HQ
Haifa, IL
Employees
106

Pluri Biotech (פלורי ביוטק בע"מ, formerly Pluristem Therapeutics) is a clinical-stage biotherapy company developing cell therapies.

View company
Bolt Biotherapeutics
HQ
Redwood City, US
Employees
52↓ 48% decrease

Bolt Biotherapeutics is a biotechnology company developing immunotherapeutics for multiple types of cancer.

View company
Eleven Tx
HQ
Tel Aviv-Yafo, IL
Employees
29

Eleven Therapeutics is a biotechnology company focused on using ribonucleic acid interference (RNAi) for nucleic acid therapeutics.

View company